Vitamin K Antagonist
Pregnancy: D
Warfarin
Brand names: Coumadin, Marevan
Adult dose
Dose: Induction: 10 mg day 1 (or 5 mg if elderly/comorbid); maintenance dose titrated to INR
Route: oral
Frequency: once daily (same time each evening)
Max: Titrated to INR target
INR targets: AF/VTE: 2–3; mechanical mitral valve: 3–4; if 2 INR values outside range at same appointment → refer to anticoagulation service
Paediatric dose
Dose: 0.2 mg/kg
Route: oral
Frequency: once daily
Max: 10 mg loading
Concentration: 1 mg, 3 mg, 5 mg tablets mg/ml
Specialist use; INR monitoring more frequent in children due to dietary variability; vitamin K intake consistency important
Dose adjustments
Renal
No dose adjustment required (but increased bleeding risk in CKD)
Hepatic
Increased sensitivity — significant liver disease greatly increases INR
Paediatric weight-based calculator
Specialist use; INR monitoring more frequent in children due to dietary variability; vitamin K intake consistency important
Clinical pearls
- Yellow warfarin 5 mg, brown 1 mg, blue 3 mg — standard UK colour coding
- Dietary consistency: advise consistent vitamin K intake (leafy green vegetables) — not avoidance
- Reversal: vitamin K oral/IV for over-anticoagulation; 4-factor PCC (Beriplex/Octaplex) for urgent reversal
Contraindications
- Pregnancy first trimester (warfarin embryopathy)
- Active bleeding
- Recent surgery/trauma with high bleeding risk
- Unsupervised patient unable to comply with monitoring
Side effects
- Haemorrhage (all sites)
- Skin necrosis (protein C/S deficiency — early initiation without heparin cover)
- Purple toe syndrome (cholesterol embolism)
- Teratogenicity
Interactions
- Hundreds of interactions — check every new drug; amiodarone/fluconazole/NSAIDs increase INR; rifampicin/carbamazepine reduce INR
- Alcohol: binge drinking increases INR
Monitoring
- INR (initially daily/alternate days until stable, then 8–12 weekly)
- MHRA yellow anticoagulant booklet issued to all patients
Reference: BNFc; BNF 86; BCSH guidelines; NICE NG196. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Peripheral Arterial Disease · NICE NG19 2012 / ESVS 2017
- Carotid Artery Disease · NICE CG68 / ESVS 2018
- Varicose Veins Management · NICE CG168 2013
- Venous Leg Ulcer Management · NICE NG204 2022
- Major Haemorrhage / Massive Transfusion · BCSH; RCOA; RCEM; RCS — BCSH Guidelines
- Anaemia Investigation · BSH / NICE